Since the initial US Food and Drug Administration (FDA) approval of Kymriah in 2017, interest in cell therapies has exploded, with seven cell therapies on the market and over 2,800 in development. This rapid growth holds immense promise for patients, but conventional contract development and manufacturing organizations (CDMOs) are unable to meet the excessive patient demand for these life-saving cell therapies. As a result, patients are dying on the waitlist even though they are eligible for FDA-approved cell therapies.
In this webinar, the expert speaker will introduce a novel approach to the mass manufacturing of personalized living drugs. Cellares’ global network of smart factories can produce ten times more cell therapy batches per year than conventional CDMO facilities. This productivity jump is enabled by Cellares’ Cell Shuttle manufacturing platform, which reduces labor and facility size by 90 percent.
Register for this webinar today to gain insights into a novel approach that can be useful for large-scale cell therapy manufacturing.
Speaker
Fabian Gerlighaus, Co-Founder and CEO, Cellares
Fabian Gerlinghaus is Co-Founder and Chief Executive Officer of Cellares. He is driven by a strong sense of purpose and is passionate about meeting total patient demand for cell therapies globally. With over 10 years of experience as an innovator and a leader, Fabian has established a track record of assembling top-performing teams to successfully drive novel bioprocessing technologies from ideation to commercial readiness. Prior to co-founding Cellares, Fabian served as Chief Innovation Officer at Synthego, where he co-invented the company’s proprietary RNA synthesizer technology and helped grow the company from five to more than 230 employees. He successfully led the interdisciplinary team that took synthesizer technology from a whiteboard sketch to production-ready instruments within two years, enabling the company to be the first to market its CRISPR/Cas9 product portfolio. He holds a Master’s degree in Aerospace Engineering from the Technical University of Munich and an Honors degree in Technology Management from the Center for Digital Technology and Management, Munich.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Cell Therapy Scientists and Researchers
- Manufacturing and Process Development Scientists
- Quality Control and Assurance Professionals
- Regulatory Affairs
- Bioprocessing Managers
- Cell Therapy Product Developers
- Industry Consultants and Analysts
- Academics and students interested in cell therapy manufacturing
What You Will Learn
Attendees will learn about:
- Cellares’ global network of cGMP IDMO smart factories, which can produce ten times more cell therapy batches per year than conventional CDMO facilities, with the same workforce and the same footprint
- Cellares’ Cell Shuttle manufacturing platform, which reduces labor and facility size by 90 percent
Xtalks Partner
Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at a global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.
The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account